49,164 Orion Corporation A shares converted into B shares

Company Overview - Orion Corporation is a Nordic pharmaceutical company with over a hundred years of experience in developing, manufacturing, and marketing human and veterinary pharmaceuticals as well as active pharmaceutical ingredients [2] - The company has a diverse portfolio that includes proprietary and generic medicines, as well as consumer health products, focusing on oncology and pain as core therapy areas in its pharmaceutical R&D [2] - In 2024, Orion's net sales reached EUR 1,542 million, and the company employed approximately 3,700 professionals globally [2] Share Conversion - A total of 49,164 A shares of Orion Corporation have been converted into B shares, with the conversion recorded in the Trade Register on 24 October 2025 [1] - Following the conversion, the total number of shares in Orion Corporation is 141,134,278, consisting of 31,841,817 A shares and 109,292,461 B shares [1] - The total number of votes associated with the company's shares after the conversion is 746,128,801 [1]